医学
塞鲁美替尼
神经纤维瘤病
结节性硬化
视网膜
错构瘤
病理
遗传性疾病
纤维神经瘤
皮肤病科
光盘
视网膜病变
无虹膜
视网膜病变
眼科
视网膜脱离
视网膜色素上皮
疣
视网膜
丛状神经纤维瘤
作者
T H Wang,Yuchen He,Xuemei Zhu,Jianhong Liang
出处
期刊:Pediatrics
[American Academy of Pediatrics]
日期:2026-02-19
卷期号:157 (3)
标识
DOI:10.1542/peds.2025-071507
摘要
Retinal astrocytic hamartoma (RAH) is a rare benign retinal tumor most commonly associated with tuberous sclerosis complex and is typically stable. RAH may also rarely occur in neurofibromatosis type 1 (NF1), an autosomal dominant disorder characterized by skin pigmentation abnormalities and multiple neurofibromas. We present a case of a child with NF1 and symptomatic, inoperable plexiform neurofibromas, for which selumetinib was initiated. Incidentally, the patient also had a progressive RAH involving the optic disc, leading to severe exudative retinal detachment. Following selumetinib therapy, the RAH showed measurable reduction in size (from 5.51 × 10.69 mm to 5.46 × 5.23 mm on ocular ultrasonography) and resolution of associated retinal detachment This case highlights a novel observation of selumetinib-associated RAH regression in an a patient with NF1. Although selumetinib was not prescribed for ocular disease, these findings suggest a potential off-target benefit and support further exploration of mitogen-activated protein kinase inhibitors in managing vision-threatening RAH in NF1.
科研通智能强力驱动
Strongly Powered by AbleSci AI